Global Porcine Vaccines Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Porcine Vaccines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Porcine Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 CSF Vaccines
  • 1.2.3 FMD Vaccines
  • 1.2.4 Porcine Circovirus Vaccines
  • 1.2.5 PRRS Vaccines
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Porcine Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Government Tender
  • 1.3.3 Market Sales
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Porcine Vaccines Sales Estimates and Forecasts 2017-2028
• 2.2 Global Porcine Vaccines Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Porcine Vaccines Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Porcine Vaccines Sales by Region
  • 2.4.1 Global Porcine Vaccines Sales by Region (2017-2022)
  • 2.4.2 Global Sales Porcine Vaccines by Region (2023-2028)
• 2.5 Global Porcine Vaccines Revenue by Region
  • 2.5.1 Global Porcine Vaccines Revenue by Region (2017-2022)
  • 2.5.2 Global Porcine Vaccines Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Porcine Vaccines Sales by Manufacturers
  • 3.1.1 Global Top Porcine Vaccines Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Porcine Vaccines Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Porcine Vaccines in 2021
• 3.2 Global Porcine Vaccines Revenue by Manufacturers
  • 3.2.1 Global Porcine Vaccines Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Porcine Vaccines Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Porcine Vaccines Revenue in 2021
• 3.3 Global Porcine Vaccines Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Porcine Vaccines Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Porcine Vaccines Sales by Type
  • 4.1.1 Global Porcine Vaccines Historical Sales by Type (2017-2022)
  • 4.1.2 Global Porcine Vaccines Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Porcine Vaccines Sales Market Share by Type (2017-2028)
• 4.2 Global Porcine Vaccines Revenue by Type
  • 4.2.1 Global Porcine Vaccines Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Porcine Vaccines Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Porcine Vaccines Revenue Market Share by Type (2017-2028)
• 4.3 Global Porcine Vaccines Price by Type
  • 4.3.1 Global Porcine Vaccines Price by Type (2017-2022)
  • 4.3.2 Global Porcine Vaccines Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Porcine Vaccines Sales by Application
  • 5.1.1 Global Porcine Vaccines Historical Sales by Application (2017-2022)
  • 5.1.2 Global Porcine Vaccines Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Porcine Vaccines Sales Market Share by Application (2017-2028)
• 5.2 Global Porcine Vaccines Revenue by Application
  • 5.2.1 Global Porcine Vaccines Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Porcine Vaccines Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Porcine Vaccines Revenue Market Share by Application (2017-2028)
• 5.3 Global Porcine Vaccines Price by Application
  • 5.3.1 Global Porcine Vaccines Price by Application (2017-2022)
  • 5.3.2 Global Porcine Vaccines Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Porcine Vaccines Market Size by Type
  • 6.1.1 North America Porcine Vaccines Sales by Type (2017-2028)
  • 6.1.2 North America Porcine Vaccines Revenue by Type (2017-2028)
• 6.2 North America Porcine Vaccines Market Size by Application
  • 6.2.1 North America Porcine Vaccines Sales by Application (2017-2028)
  • 6.2.2 North America Porcine Vaccines Revenue by Application (2017-2028)
• 6.3 North America Porcine Vaccines Market Size by Country
  • 6.3.1 North America Porcine Vaccines Sales by Country (2017-2028)
  • 6.3.2 North America Porcine Vaccines Revenue by Country (2017-2028)
  • 6.3.3 the United States
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Porcine Vaccines Market Size by Type
  • 7.1.1 Europe Porcine Vaccines Sales by Type (2017-2028)
  • 7.1.2 Europe Porcine Vaccines Revenue by Type (2017-2028)
• 7.2 Europe Porcine Vaccines Market Size by Application
  • 7.2.1 Europe Porcine Vaccines Sales by Application (2017-2028)
  • 7.2.2 Europe Porcine Vaccines Revenue by Application (2017-2028)
• 7.3 Europe Porcine Vaccines Market Size by Country
  • 7.3.1 Europe Porcine Vaccines Sales by Country (2017-2028)
  • 7.3.2 Europe Porcine Vaccines Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 UK
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Porcine Vaccines Market Size by Type
  • 8.1.1 Asia Pacific Porcine Vaccines Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Porcine Vaccines Revenue by Type (2017-2028)
• 8.2 Asia Pacific Porcine Vaccines Market Size by Application
  • 8.2.1 Asia Pacific Porcine Vaccines Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Porcine Vaccines Revenue by Application (2017-2028)
• 8.3 Asia Pacific Porcine Vaccines Market Size by Region
  • 8.3.1 Asia Pacific Porcine Vaccines Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Porcine Vaccines Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Porcine Vaccines Market Size by Type
  • 9.1.1 Latin America Porcine Vaccines Sales by Type (2017-2028)
  • 9.1.2 Latin America Porcine Vaccines Revenue by Type (2017-2028)
• 9.2 Latin America Porcine Vaccines Market Size by Application
  • 9.2.1 Latin America Porcine Vaccines Sales by Application (2017-2028)
  • 9.2.2 Latin America Porcine Vaccines Revenue by Application (2017-2028)
• 9.3 Latin America Porcine Vaccines Market Size by Country
  • 9.3.1 Latin America Porcine Vaccines Sales by Country (2017-2028)
  • 9.3.2 Latin America Porcine Vaccines Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Porcine Vaccines Market Size by Type
  • 10.1.1 Middle East and Africa Porcine Vaccines Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Porcine Vaccines Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Porcine Vaccines Market Size by Application
  • 10.2.1 Middle East and Africa Porcine Vaccines Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Porcine Vaccines Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Porcine Vaccines Market Size by Country
  • 10.3.1 Middle East and Africa Porcine Vaccines Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Porcine Vaccines Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Merck
  • 11.1.1 Merck Corporation Information
  • 11.1.2 Merck Overview
  • 11.1.3 Merck Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Merck Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Merck Recent Developments
• 11.2 Boehringer Ingelheim
  • 11.2.1 Boehringer Ingelheim Corporation Information
  • 11.2.2 Boehringer Ingelheim Overview
  • 11.2.3 Boehringer Ingelheim Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Boehringer Ingelheim Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Boehringer Ingelheim Recent Developments
• 11.3 Jinyu Bio-Technology
  • 11.3.1 Jinyu Bio-Technology Corporation Information
  • 11.3.2 Jinyu Bio-Technology Overview
  • 11.3.3 Jinyu Bio-Technology Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Jinyu Bio-Technology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Jinyu Bio-Technology Recent Developments
• 11.4 CAHIC
  • 11.4.1 CAHIC Corporation Information
  • 11.4.2 CAHIC Overview
  • 11.4.3 CAHIC Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 CAHIC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 CAHIC Recent Developments
• 11.5 Tecon
  • 11.5.1 Tecon Corporation Information
  • 11.5.2 Tecon Overview
  • 11.5.3 Tecon Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Tecon Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Tecon Recent Developments
• 11.6 Zoetis
  • 11.6.1 Zoetis Corporation Information
  • 11.6.2 Zoetis Overview
  • 11.6.3 Zoetis Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Zoetis Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Zoetis Recent Developments
• 11.7 Ceva
  • 11.7.1 Ceva Corporation Information
  • 11.7.2 Ceva Overview
  • 11.7.3 Ceva Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Ceva Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Ceva Recent Developments
• 11.8 Hile Bio
  • 11.8.1 Hile Bio Corporation Information
  • 11.8.2 Hile Bio Overview
  • 11.8.3 Hile Bio Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Hile Bio Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Hile Bio Recent Developments
• 11.9 Chopper Biology
  • 11.9.1 Chopper Biology Corporation Information
  • 11.9.2 Chopper Biology Overview
  • 11.9.3 Chopper Biology Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Chopper Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Chopper Biology Recent Developments
• 11.10 WINSUN
  • 11.10.1 WINSUN Corporation Information
  • 11.10.2 WINSUN Overview
  • 11.10.3 WINSUN Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 WINSUN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 WINSUN Recent Developments
• 11.11 Hipra
  • 11.11.1 Hipra Corporation Information
  • 11.11.2 Hipra Overview
  • 11.11.3 Hipra Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Hipra Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Hipra Recent Developments
• 11.12 Ringpu Biology
  • 11.12.1 Ringpu Biology Corporation Information
  • 11.12.2 Ringpu Biology Overview
  • 11.12.3 Ringpu Biology Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Ringpu Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Ringpu Biology Recent Developments
• 11.13 ChengDu Tecbond
  • 11.13.1 ChengDu Tecbond Corporation Information
  • 11.13.2 ChengDu Tecbond Overview
  • 11.13.3 ChengDu Tecbond Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 ChengDu Tecbond Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 ChengDu Tecbond Recent Developments
• 11.14 DHN
  • 11.14.1 DHN Corporation Information
  • 11.14.2 DHN Overview
  • 11.14.3 DHN Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 DHN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 DHN Recent Developments
• 11.15 CAVAC
  • 11.15.1 CAVAC Corporation Information
  • 11.15.2 CAVAC Overview
  • 11.15.3 CAVAC Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 CAVAC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 CAVAC Recent Developments
• 11.16 Virbac
  • 11.16.1 Virbac Corporation Information
  • 11.16.2 Virbac Overview
  • 11.16.3 Virbac Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.16.4 Virbac Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Virbac Recent Developments
• 11.17 HVRI
  • 11.17.1 HVRI Corporation Information
  • 11.17.2 HVRI Overview
  • 11.17.3 HVRI Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.17.4 HVRI Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 HVRI Recent Developments
• 11.18 Bioveta
  • 11.18.1 Bioveta Corporation Information
  • 11.18.2 Bioveta Overview
  • 11.18.3 Bioveta Porcine Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.18.4 Bioveta Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.18.5 Bioveta Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Porcine Vaccines Industry Chain Analysis
• 12.2 Porcine Vaccines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Porcine Vaccines Production Mode & Process
• 12.4 Porcine Vaccines Sales and Marketing
  • 12.4.1 Porcine Vaccines Sales Channels
  • 12.4.2 Porcine Vaccines Distributors
• 12.5 Porcine Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Porcine Vaccines Industry Trends
• 13.2 Porcine Vaccines Market Drivers
• 13.3 Porcine Vaccines Market Challenges
• 13.4 Porcine Vaccines Market Restraints

14 Key Findings in The Global Porcine Vaccines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Porcine Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of CSF Vaccines
• Table 3. Major Manufacturers of FMD Vaccines
• Table 4. Major Manufacturers of Porcine Circovirus Vaccines
• Table 5. Major Manufacturers of PRRS Vaccines
• Table 6. Major Manufacturers of Other
• Table 7. Global Porcine Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Porcine Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 9. Global Porcine Vaccines Sales by Region (2017-2022) & (Units)
• Table 10. Global Porcine Vaccines Sales Market Share by Region (2017-2022)
• Table 11. Global Porcine Vaccines Sales by Region (2023-2028) & (Units)
• Table 12. Global Porcine Vaccines Sales Market Share by Region (2023-2028)
• Table 13. Global Porcine Vaccines Revenue by Region (2017-2022) & (US$ Million)
• Table 14. Global Porcine Vaccines Revenue Market Share by Region (2017-2022)
• Table 15. Global Porcine Vaccines Revenue by Region (2023-2028) & (US$ Million)
• Table 16. Global Porcine Vaccines Revenue Market Share by Region (2023-2028)
• Table 17. Global Porcine Vaccines Sales by Manufacturers (2017-2022) & (Units)
• Table 18. Global Porcine Vaccines Sales Share by Manufacturers (2017-2022)
• Table 19. Global Porcine Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 20. Global Porcine Vaccines Revenue Share by Manufacturers (2017-2022)
• Table 21. Porcine Vaccines Price by Manufacturers (2017-2022) &(K USD/Unit)
• Table 22. Global Porcine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Porcine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Vaccines as of 2021)
• Table 24. Porcine Vaccines Manufacturing Base Distribution and Headquarters
• Table 25. Manufacturers Porcine Vaccines Product Offered
• Table 26. Date of Manufacturers Enter into Porcine Vaccines Market
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Porcine Vaccines Sales by Type (2017-2022) & (Units)
• Table 29. Global Porcine Vaccines Sales by Type (2023-2028) & (Units)
• Table 30. Global Porcine Vaccines Sales Share by Type (2017-2022)
• Table 31. Global Porcine Vaccines Sales Share by Type (2023-2028)
• Table 32. Global Porcine Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 33. Global Porcine Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 34. Global Porcine Vaccines Revenue Share by Type (2017-2022)
• Table 35. Global Porcine Vaccines Revenue Share by Type (2023-2028)
• Table 36. Porcine Vaccines Price by Type (2017-2022) & (K USD/Unit)
• Table 37. Global Porcine Vaccines Price Forecast by Type (2023-2028) & (K USD/Unit)
• Table 38. Global Porcine Vaccines Sales by Application (2017-2022) & (Units)
• Table 39. Global Porcine Vaccines Sales by Application (2023-2028) & (Units)
• Table 40. Global Porcine Vaccines Sales Share by Application (2017-2022)
• Table 41. Global Porcine Vaccines Sales Share by Application (2023-2028)
• Table 42. Global Porcine Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 43. Global Porcine Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 44. Global Porcine Vaccines Revenue Share by Application (2017-2022)
• Table 45. Global Porcine Vaccines Revenue Share by Application (2023-2028)
• Table 46. Porcine Vaccines Price by Application (2017-2022) & (K USD/Unit)
• Table 47. Global Porcine Vaccines Price Forecast by Application (2023-2028) & (K USD/Unit)
• Table 48. North America Porcine Vaccines Sales by Type (2017-2022) & (Units)
• Table 49. North America Porcine Vaccines Sales by Type (2023-2028) & (Units)
• Table 50. North America Porcine Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 51. North America Porcine Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 52. North America Porcine Vaccines Sales by Application (2017-2022) & (Units)
• Table 53. North America Porcine Vaccines Sales by Application (2023-2028) & (Units)
• Table 54. North America Porcine Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 55. North America Porcine Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 56. North America Porcine Vaccines Sales by Country (2017-2022) & (Units)
• Table 57. North America Porcine Vaccines Sales by Country (2023-2028) & (Units)
• Table 58. North America Porcine Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 59. North America Porcine Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 60. Europe Porcine Vaccines Sales by Type (2017-2022) & (Units)
• Table 61. Europe Porcine Vaccines Sales by Type (2023-2028) & (Units)
• Table 62. Europe Porcine Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 63. Europe Porcine Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 64. Europe Porcine Vaccines Sales by Application (2017-2022) & (Units)
• Table 65. Europe Porcine Vaccines Sales by Application (2023-2028) & (Units)
• Table 66. Europe Porcine Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 67. Europe Porcine Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 68. Europe Porcine Vaccines Sales by Country (2017-2022) & (Units)
• Table 69. Europe Porcine Vaccines Sales by Country (2023-2028) & (Units)
• Table 70. Europe Porcine Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 71. Europe Porcine Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 72. Asia Pacific Porcine Vaccines Sales by Type (2017-2022) & (Units)
• Table 73. Asia Pacific Porcine Vaccines Sales by Type (2023-2028) & (Units)
• Table 74. Asia Pacific Porcine Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 75. Asia Pacific Porcine Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 76. Asia Pacific Porcine Vaccines Sales by Application (2017-2022) & (Units)
• Table 77. Asia Pacific Porcine Vaccines Sales by Application (2023-2028) & (Units)
• Table 78. Asia Pacific Porcine Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 79. Asia Pacific Porcine Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 80. Asia Pacific Porcine Vaccines Sales by Region (2017-2022) & (Units)
• Table 81. Asia Pacific Porcine Vaccines Sales by Region (2023-2028) & (Units)
• Table 82. Asia Pacific Porcine Vaccines Revenue by Region (2017-2022) & (US$ Million)
• Table 83. Asia Pacific Porcine Vaccines Revenue by Region (2023-2028) & (US$ Million)
• Table 84. Latin America Porcine Vaccines Sales by Type (2017-2022) & (Units)
• Table 85. Latin America Porcine Vaccines Sales by Type (2023-2028) & (Units)
• Table 86. Latin America Porcine Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 87. Latin America Porcine Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 88. Latin America Porcine Vaccines Sales by Application (2017-2022) & (Units)
• Table 89. Latin America Porcine Vaccines Sales by Application (2023-2028) & (Units)
• Table 90. Latin America Porcine Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 91. Latin America Porcine Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 92. Latin America Porcine Vaccines Sales by Country (2017-2022) & (Units)
• Table 93. Latin America Porcine Vaccines Sales by Country (2023-2028) & (Units)
• Table 94. Latin America Porcine Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 95. Latin America Porcine Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 96. Middle East and Africa Porcine Vaccines Sales by Type (2017-2022) & (Units)
• Table 97. Middle East and Africa Porcine Vaccines Sales by Type (2023-2028) & (Units)
• Table 98. Middle East and Africa Porcine Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 99. Middle East and Africa Porcine Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 100. Middle East and Africa Porcine Vaccines Sales by Application (2017-2022) & (Units)
• Table 101. Middle East and Africa Porcine Vaccines Sales by Application (2023-2028) & (Units)
• Table 102. Middle East and Africa Porcine Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 103. Middle East and Africa Porcine Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 104. Middle East and Africa Porcine Vaccines Sales by Country (2017-2022) & (Units)
• Table 105. Middle East and Africa Porcine Vaccines Sales by Country (2023-2028) & (Units)
• Table 106. Middle East and Africa Porcine Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 107. Middle East and Africa Porcine Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 108. Merck Corporation Information
• Table 109. Merck Description and Major Businesses
• Table 110. Merck Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 111. Merck Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. Merck Recent Developments
• Table 113. Boehringer Ingelheim Corporation Information
• Table 114. Boehringer Ingelheim Description and Major Businesses
• Table 115. Boehringer Ingelheim Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 116. Boehringer Ingelheim Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Boehringer Ingelheim Recent Developments
• Table 118. Jinyu Bio-Technology Corporation Information
• Table 119. Jinyu Bio-Technology Description and Major Businesses
• Table 120. Jinyu Bio-Technology Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 121. Jinyu Bio-Technology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. Jinyu Bio-Technology Recent Developments
• Table 123. CAHIC Corporation Information
• Table 124. CAHIC Description and Major Businesses
• Table 125. CAHIC Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 126. CAHIC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. CAHIC Recent Developments
• Table 128. Tecon Corporation Information
• Table 129. Tecon Description and Major Businesses
• Table 130. Tecon Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 131. Tecon Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. Tecon Recent Developments
• Table 133. Zoetis Corporation Information
• Table 134. Zoetis Description and Major Businesses
• Table 135. Zoetis Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 136. Zoetis Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. Zoetis Recent Developments
• Table 138. Ceva Corporation Information
• Table 139. Ceva Description and Major Businesses
• Table 140. Ceva Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 141. Ceva Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. Ceva Recent Developments
• Table 143. Hile Bio Corporation Information
• Table 144. Hile Bio Description and Major Businesses
• Table 145. Hile Bio Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 146. Hile Bio Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. Hile Bio Recent Developments
• Table 148. Chopper Biology Corporation Information
• Table 149. Chopper Biology Description and Major Businesses
• Table 150. Chopper Biology Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 151. Chopper Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. Chopper Biology Recent Developments
• Table 153. WINSUN Corporation Information
• Table 154. WINSUN Description and Major Businesses
• Table 155. WINSUN Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 156. WINSUN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 157. WINSUN Recent Developments
• Table 158. Hipra Corporation Information
• Table 159. Hipra Description and Major Businesses
• Table 160. Hipra Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 161. Hipra Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 162. Hipra Recent Developments
• Table 163. Ringpu Biology Corporation Information
• Table 164. Ringpu Biology Description and Major Businesses
• Table 165. Ringpu Biology Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 166. Ringpu Biology Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 167. Ringpu Biology Recent Developments
• Table 168. ChengDu Tecbond Corporation Information
• Table 169. ChengDu Tecbond Description and Major Businesses
• Table 170. ChengDu Tecbond Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 171. ChengDu Tecbond Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 172. ChengDu Tecbond Recent Developments
• Table 173. DHN Corporation Information
• Table 174. DHN Description and Major Businesses
• Table 175. DHN Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 176. DHN Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 177. DHN Recent Developments
• Table 178. CAVAC Corporation Information
• Table 179. CAVAC Description and Major Businesses
• Table 180. CAVAC Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 181. CAVAC Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 182. CAVAC Recent Developments
• Table 183. Virbac Corporation Information
• Table 184. Virbac Description and Major Businesses
• Table 185. Virbac Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 186. Virbac Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 187. Virbac Recent Developments
• Table 188. HVRI Corporation Information
• Table 189. HVRI Description and Major Businesses
• Table 190. HVRI Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 191. HVRI Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 192. HVRI Recent Developments
• Table 193. Bioveta Corporation Information
• Table 194. Bioveta Description and Major Businesses
• Table 195. Bioveta Porcine Vaccines Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
• Table 196. Bioveta Porcine Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 197. Bioveta Recent Developments
• Table 198. Key Raw Materials Lists
• Table 199. Raw Materials Key Suppliers Lists
• Table 200. Porcine Vaccines Distributors List
• Table 201. Porcine Vaccines Customers List
• Table 202. Porcine Vaccines Market Trends
• Table 203. Porcine Vaccines Market Drivers
• Table 204. Porcine Vaccines Market Challenges
• Table 205. Porcine Vaccines Market Restraints
• Table 206. Research Programs/Design for This Report
• Table 207. Key Data Information from Secondary Sources
• Table 208. Key Data Information from Primary Sources

List of Figures

• Figure 1. Porcine Vaccines Product Picture
• Figure 3. Global Porcine Vaccines Market Share by Type in 2021 & 2028
• Figure 3. CSF Vaccines Product Picture
• Figure 4. FMD Vaccines Product Picture
• Figure 5. Porcine Circovirus Vaccines Product Picture
• Figure 6. PRRS Vaccines Product Picture
• Figure 7. Other Product Picture
• Figure 8. Global Porcine Vaccines Market Share by Application in 2021 & 2028
• Figure 9. Government Tender
• Figure 10. Market Sales
• Figure 11. Porcine Vaccines Report Years Considered
• Figure 12. Global Porcine Vaccines Sales 2017-2028 (Units)
• Figure 13. Global Porcine Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 14. Global Porcine Vaccines Revenue 2017-2028 (US$ Million)
• Figure 15. Global Porcine Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 16. Global Porcine Vaccines Sales Market Share by Region (2017-2022)
• Figure 17. Global Porcine Vaccines Sales Market Share by Region (2023-2028)
• Figure 18. North America Porcine Vaccines Sales YoY (2017-2028) & (Units)
• Figure 19. North America Porcine Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Europe Porcine Vaccines Sales YoY (2017-2028) & (Units)
• Figure 21. Europe Porcine Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Asia-Pacific Porcine Vaccines Sales YoY (2017-2028) & (Units)
• Figure 23. Asia-Pacific Porcine Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Latin America Porcine Vaccines Sales YoY (2017-2028) & (Units)
• Figure 25. Latin America Porcine Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. Middle East & Africa Porcine Vaccines Sales YoY (2017-2028) & (Units)
• Figure 27. Middle East & Africa Porcine Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 28. The Porcine Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 29. The Top 5 and 10 Largest Manufacturers of Porcine Vaccines in the World: Market Share by Porcine Vaccines Revenue in 2021
• Figure 30. Global Porcine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 31. Global Porcine Vaccines Sales Market Share by Type (2017-2028)
• Figure 32. Global Porcine Vaccines Revenue Market Share by Type (2017-2028)
• Figure 33. Global Porcine Vaccines Sales Market Share by Application (2017-2028)
• Figure 34. Global Porcine Vaccines Revenue Market Share by Application (2017-2028)
• Figure 35. North America Porcine Vaccines Sales Market Share by Type (2017-2028)
• Figure 36. North America Porcine Vaccines Revenue Market Share by Type (2017-2028)
• Figure 37. North America Porcine Vaccines Sales Market Share by Application (2017-2028)
• Figure 38. North America Porcine Vaccines Revenue Market Share by Application (2017-2028)
• Figure 39. North America Porcine Vaccines Sales Share by Country (2017-2028)
• Figure 40. North America Porcine Vaccines Revenue Share by Country (2017-2028)
• Figure 41. the United States Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 42. Canada Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 43. Europe Porcine Vaccines Sales Market Share by Type (2017-2028)
• Figure 44. Europe Porcine Vaccines Revenue Market Share by Type (2017-2028)
• Figure 45. Europe Porcine Vaccines Sales Market Share by Application (2017-2028)
• Figure 46. Europe Porcine Vaccines Revenue Market Share by Application (2017-2028)
• Figure 47. Europe Porcine Vaccines Sales Share by Country (2017-2028)
• Figure 48. Europe Porcine Vaccines Revenue Share by Country (2017-2028)
• Figure 49. Germany Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 50. France Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 51. UK Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 52. Italy Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 53. Russia Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 54. Asia Pacific Porcine Vaccines Sales Market Share by Type (2017-2028)
• Figure 55. Asia Pacific Porcine Vaccines Revenue Market Share by Type (2017-2028)
• Figure 56. Asia Pacific Porcine Vaccines Sales Market Share by Application (2017-2028)
• Figure 57. Asia Pacific Porcine Vaccines Revenue Market Share by Application (2017-2028)
• Figure 58. Asia Pacific Porcine Vaccines Sales Share by Region (2017-2028)
• Figure 59. Asia Pacific Porcine Vaccines Revenue Share by Region (2017-2028)
• Figure 60. China Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 61. Japan Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 62. South Korea Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 63. India Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 64. Australia Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 65. China Taiwan Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 66. Indonesia Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 67. Thailand Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 68. Malaysia Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 69. Latin America Porcine Vaccines Sales Market Share by Type (2017-2028)
• Figure 70. Latin America Porcine Vaccines Revenue Market Share by Type (2017-2028)
• Figure 71. Latin America Porcine Vaccines Sales Market Share by Application (2017-2028)
• Figure 72. Latin America Porcine Vaccines Revenue Market Share by Application (2017-2028)
• Figure 73. Latin America Porcine Vaccines Sales Share by Country (2017-2028)
• Figure 74. Latin America Porcine Vaccines Revenue Share by Country (2017-2028)
• Figure 75. Mexico Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 76. Brazil Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 77. Argentina Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 78. Middle East and Africa Porcine Vaccines Sales Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Porcine Vaccines Revenue Market Share by Type (2017-2028)
• Figure 80. Middle East and Africa Porcine Vaccines Sales Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Porcine Vaccines Revenue Market Share by Application (2017-2028)
• Figure 82. Middle East and Africa Porcine Vaccines Sales Share by Country (2017-2028)
• Figure 83. Middle East and Africa Porcine Vaccines Revenue Share by Country (2017-2028)
• Figure 84. Turkey Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 85. Saudi Arabia Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 86. UAE Porcine Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 87. Porcine Vaccines Value Chain
• Figure 88. Porcine Vaccines Production Process
• Figure 89. Channels of Distribution
• Figure 90. Distributors Profiles
• Figure 91. Bottom-up and Top-down Approaches for This Report
• Figure 92. Data Triangulation
• Figure 93. Key Executives Interviewed